Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 10
2004 9
2005 14
2006 6
2007 8
2008 13
2009 19
2010 13
2011 17
2012 17
2013 22
2014 23
2015 19
2016 15
2017 13
2018 14
2019 22
2020 32
2021 20
2022 26
2023 22
2024 19
2025 16
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis.
Kuwada T, Shiokawa M, Kodama Y, Ota S, Kakiuchi N, Nannya Y, Yamazaki H, Yoshida H, Nakamura T, Matsumoto S, Muramoto Y, Yamamoto S, Honzawa Y, Kuriyama K, Okamoto K, Hirano T, Okada H, Marui S, Sogabe Y, Morita T, Matsumori T, Mima A, Nishikawa Y, Ueda T, Matsumura K, Uza N, Chiba T, Seno H. Kuwada T, et al. Among authors: yoshida h. Gastroenterology. 2021 Jun;160(7):2383-2394.e21. doi: 10.1053/j.gastro.2021.02.019. Epub 2021 Feb 12. Gastroenterology. 2021. PMID: 33582126 Free article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2025 Feb;36(2):185-196. doi: 10.1016/j.annonc.2024.10.828. Epub 2024 Nov 9. Ann Oncol. 2025. PMID: 39528049 Free article. Clinical Trial.
[Deep Learning and AlphaGo].
Yoshida H. Yoshida H. Brain Nerve. 2019 Jul;71(7):681-694. doi: 10.11477/mf.1416201340. Brain Nerve. 2019. PMID: 31289242 Review. Japanese.
Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.
Haggstrom L, Lee YC, Barretina-Ginesta MP, Jaeger A, Woelber L, Woopen H, Rhind M, Frenel JS, Aanum A, Bischof K, Mongillo M, Brodsky AL, Ledermann J, Ghezelayagh TS, Boere I, Kaiser S, Maximiano C, Rosengarten O, Safra T, Pertejo A, Cecere S, Ray-Coquard I, Lheureux S, Glasspool R, Gil-Martin M, Tookman L, Kim SI, Mittelstadt S, Corbellas Aparicio M, Palacio I, Martin-Lorente C, Kristeleit R, de la Cueva H, Ottevanger N, Quindós Varela M, Yoshida H, Link T, Gaba L, Marquina G, Burdett N, Johannet P, Reichenbach J, Park-Simon TW, Klecker PH, González-Martín A, Marth C, Liebrich C, Dzotsenidze L, Heublein S, Kasherman L, Perez C, Masvidal M, Guillén Sentís P, de Gregorio N, Hemptenmacher F, Hilpert F, Sehouli J, Scott C, Tucker KM, Dong J, Fortuno C, Spurdle AB, Friedlander M; Gynecologic Cancer InterGroup Collaboration Into Exceptional Responders to PARP Inhibitors (GCIG-CERP). Haggstrom L, et al. Among authors: yoshida h. JAMA Oncol. 2026 Aug 1;12(8):845-854. doi: 10.1001/jamaoncol.2026.1924. JAMA Oncol. 2026. PMID: 42348196 Free PMC article.
CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.
Ferreira-Junior JR, Koenigkam-Santos M, Magalhães Tenório AP, Faleiros MC, Garcia Cipriano FE, Fabro AT, Näppi J, Yoshida H, de Azevedo-Marques PM. Ferreira-Junior JR, et al. Among authors: yoshida h. Int J Comput Assist Radiol Surg. 2020 Jan;15(1):163-172. doi: 10.1007/s11548-019-02093-y. Epub 2019 Nov 13. Int J Comput Assist Radiol Surg. 2020. PMID: 31722085
External validation of the eCura system and comparison with the W-eCura score for predicting lymph node metastasis after non-curative endoscopic submucosal dissection for early gastric cancer: a multicenter retrospective cohort study.
Yabuuchi Y, Masui Y, Kumagai K, Iwagami H, Murai K, Setoyama T, Tochio T, Utsumi T, Yoshikawa T, Araki O, Murakami S, Kitami M, Matsuura K, Kanda N, Hishitani E, Tanaka J, Marui S, Ikuta K, Yoshida H, Nishikawa Y, Nakanishi Y, Seno H; KONOE Project. Yabuuchi Y, et al. Among authors: yoshida h. J Gastroenterol. 2025 Jul;60(7):829-837. doi: 10.1007/s00535-025-02261-9. Epub 2025 May 12. J Gastroenterol. 2025. PMID: 40350513
372 results